387570 — Finemedix Co Balance Sheet
0.000.00%
- KR₩37bn
- KR₩35bn
- KR₩10bn
Annual balance sheet for Finemedix Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2,749 | 2,585 | 2,671 | 10,415 | 6,141 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,334 | 2,311 | 2,685 | 2,904 | 3,034 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6,054 | 7,325 | 7,841 | 16,785 | 14,385 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10,156 | 10,117 | 9,446 | 9,095 | 9,248 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 20,169 | 18,568 | 18,526 | 26,898 | 25,521 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,117 | 3,957 | 3,160 | 3,124 | 2,713 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 9,404 | 6,997 | 5,904 | 6,114 | 6,518 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 10,764 | 11,571 | 12,622 | 20,784 | 19,003 |
| Total Liabilities & Shareholders' Equity | 20,169 | 18,568 | 18,526 | 26,898 | 25,521 |
| Total Common Shares Outstanding |